Apparent Mineralocorticoid Excess Latest Advances

Find the Latest Research About Apparent Mineralocorticoid Excess

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 413 publications

Acquired apparent mineralocorticoid excess induced by compound glycyrrhizin tablets: A case report and literature review.

Acquired apparent mineralocorticoid excess induced by compound glycyrrhizin tablets: A case report and literature review.

Journal: International journal of clinical pharmacology and therapeutics

Published: August 03, 2026

A rare genetically confirmed case of apparent mineralocorticoid excess syndrome due to a homozygous HSD11B2 variant in a 2-year-old child with severe hypertension: response to targeted therapy.

A rare genetically confirmed case of apparent mineralocorticoid excess syndrome due to a homozygous HSD11B2 variant in a 2-year-old child with severe hypertension: response to targeted therapy.

Journal: Clinical and experimental pediatrics

Published: May 31, 2026

A case report of apparent mineralocorticoid excess syndrome induced by a licorice preparation

A case report of apparent mineralocorticoid excess syndrome induced by a licorice preparation

Journal: Zhonghua nei ke za zhi

Published: May 08, 2026

Liddle syndrome caused by SCNN1B mutation presenting with severe early-onset hypertension and hypokalemia in an adolescent: a case report.

Liddle syndrome caused by SCNN1B mutation presenting with severe early-onset hypertension and hypokalemia in an adolescent: a case report.

Journal: BMC endocrine disorders

Published: March 25, 2026

Low-renin hypertension.

Low-renin hypertension.

Journal: Vitamins and hormones

Published: February 04, 2026

Endocrine consequences of antifungal therapy: A missed entity.

Endocrine consequences of antifungal therapy: A missed entity.

Journal: World journal of clinical cases

Published: December 01, 2025

Driving hypertension: non-classic apparent mineralocorticoid excess.

Driving hypertension: non-classic apparent mineralocorticoid excess.

Journal: Nature reviews. Endocrinology

Published: November 12, 2025

Apparent mineralocorticoid excess with a novel HSD11B2 variant: longitudinal clinical and biochemical follow-Up.

Apparent mineralocorticoid excess with a novel HSD11B2 variant: longitudinal clinical and biochemical follow-Up.

Journal: JCEM case reports

Published: September 30, 2025

A rare case of apparent mineralocorticoid excess induced by chronic liquorice ingestion.

A rare case of apparent mineralocorticoid excess induced by chronic liquorice ingestion.

Journal: Endocrinology, diabetes & metabolism case reports

Published: August 24, 2025

Population-based estimates of the global prevalence and carrier frequency of apparent mineralocorticoid excess caused by 11β-hydroxysteroid dehydrogenase type 2 deficiency.

Population-based estimates of the global prevalence and carrier frequency of apparent mineralocorticoid excess caused by 11β-hydroxysteroid dehydrogenase type 2 deficiency.

Journal: Orphanet journal of rare diseases

Published: July 21, 2025

Novel homozygous pathogenic variant in HSD11B2 as a cause of apparent mineralocorticoid excess.

Novel homozygous pathogenic variant in HSD11B2 as a cause of apparent mineralocorticoid excess.

Journal: Journal of hypertension

Published: April 14, 2025

High Plasma 18β-Glycyrrhetinic Acid Levels Are Associated With More Intensive Antihypertensive Treatment, Resistant Hypertension and Apparent Mineralocorticoid Excess in Patients With Type 2 Diabetes.

High Plasma 18β-Glycyrrhetinic Acid Levels Are Associated With More Intensive Antihypertensive Treatment, Resistant Hypertension and Apparent Mineralocorticoid Excess in Patients With Type 2 Diabetes.

Journal: The Journal of nutrition

Published: March 13, 2025

Showing 1-12 of 413

Last Updated: 09/26/2026